4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides as antiviral agents
US6451811B2 · kind B2 · utility
1Cited by
11References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2001 |
| Grant date | Sep 17, 2002 |
| Priority date | — |
| Expiry date | Mar 15, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The resent invention provides a compound of Formula III which is useful for the treatment or prevention of herpes viruses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.